Lynn Han

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

Constantine S. Tam, Judith Trotman, Stephen Opat et al. · Blood · 2019 · 367 citations · Full text

Medicine, Oncology, Pharmacology +10

Genomic sites hypersensitive to ultraviolet radiation

Sanjay Premi, Lynn Han, Sameet Mehta et al. · Proceedings of the National Academy of Sciences · 2019 · 96 citations · Full text

Medicine, Genetics, Molecular Biology +14

Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial

Ravi Savarirayan, William R. Wilcox, Paul Harmatz et al. · The Lancet Child & Adolescent Health · 2023 · 64 citations

Pharmacy, Pediatrics, Pharmacotherapy +2

Health Status, Persistent Symptoms, and Effort Intolerance One Year After Acute COVID-19 Infection

Justin R. Kingery, Monika M. Safford, Paul Martin et al. · Journal of General Internal Medicine · 2022 · 59 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +10

Decreased spliceosome fidelity and egl-8 intron retention inhibit mTORC1 signaling to promote longevity

Wenming Huang, Chun Kew, Stephanie Fernandes et al. · Nature Aging · 2022 · 35 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15